AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24169335
Drug: IL‐13 control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL‐13 control (10 µg/L IL‐13 + physiological saline)
Trial: 24169335
Drug: Glycyrrhizin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyrrhizin (25 µmol/L)
Trial: 24169335
Drug: Glycyrrhizin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyrrhizin (50 µmol/L)
Trial: 24169335
Drug: Glycyrrhizin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyrrhizin (75 µmol/L)
Trial: 18653640
Drug: Measles vaccination
RxNorm normalized name: Measles vaccine (live)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles vaccination using standard titre Edmonston‐Zagreb vaccine at 4.5 months of age
Trial: 18653640
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (vaccinated)
Trial: 16868892
Drug: 1.5 or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 or 3.0 mg dexamethasone (DEX) per os at 09:00 or 21:00 hours
Trial: 9150772
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of fentanyl (2 micrograms/ml) and bupivacaine (1.0 mg/ml) at a rate of 0.25 ml.kg‐1.h‐1
Trial: 9150772
Drug: Intermittent epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent epidural morphine (30 micrograms/kg every 8 h)
Trial: 7957516
Drug: Sublingual spray
RxNorm normalized name: Myoden, sublingual spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual spray (2.5 mg)
Trial: 7957516
Drug: Sublingual tablet
RxNorm normalized name: Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual tablet (5 mg)
Trial: 7957516
Drug: Peroral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral tablet (10 mg)
Trial: 21457065
Drug: Pioglitazone +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone + Metformin (PM)
Trial: 21457065
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + Glimepiride (GM)
Trial: 18339222
Drug: DHA-rich tuna
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich tuna fish oil (6 g fish oil/d, DHA 1.56 g/d, EPA 0.36 g/d)
Trial: 16545929
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (MgSO(4)) 250 mg/kg intravenous solution
Trial: 11094664
Drug: Tenoxicam 20
RxNorm normalized name: tenoxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam 20 mg intravenously
Trial: 26597577
Drug: No cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No cold therapy
Trial: 29564722
Drug: Pixantrone monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pixantrone monotherapy
Trial: 17152731
Drug: Thymomimetic Vilon
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thymomimetic Vilon (Lys‐Glu) administration
Trial: 17152731
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment for DM‐1 patients
Trial: 14974912
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (3.75 mg intramuscularly) plus tibolone (2.5 mg/day)
Trial: 14974912
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (3.75 mg intramuscularly) plus placebo
Trial: 8706769
Drug: Levosimendan 1
RxNorm normalized name: Levosimendán
DrugBank: Levosimendan (DB00922)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan 1 mg
Trial: 8907133
Drug: Levosimendan 2
RxNorm normalized name: levosimendan 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan 2 mg
Trial: 8706769
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg b.i.d.) with levosimendan
Trial: 3980061
Drug: L-dopa (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa (125 mg)
Trial: 3980061
Drug: L-dopa (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa (125 mg) plus carbidopa (12.5 mg)
Trial: 3980061
Drug: Tyrosine load
RxNorm normalized name: Tyrosine
DrugBank: Tyrosine (DB00135)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tyrosine load (100 mg/kg)
Trial: 31426299
Drug: L. plantarum
RxNorm normalized name: Lactobacillus acidophilus/L. plantarum/Bifido no.7 15 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. plantarum HEAL9 and L. paracasei 8700:2 (probiotic group)
Trial: 26602073
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg plus Ezetimibe 10 mg
Trial: 19797013
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (0.1 mg triptorelin administered on day 3 after embryo transfer)
Trial: 17026560
Drug: Adrenaline injection
RxNorm normalized name: epinephrine Injection [Adrenalin]
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adrenaline injection with detachable snare (group A)
Trial: 17026560
Drug: Adrenaline injection
RxNorm normalized name: epinephrine Injection [Adrenalin]
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adrenaline injection alone (group B)
Trial: 12777340
Drug: Tapering off
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering off plus group CBT
Trial: 12777340
Drug: Tapering off
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering off alone
Trial: 9378207
Drug: Pancreatic duct
RxNorm normalized name: Sus scrofa bile duct preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancreatic duct injections (10 or more injections) in Group I
Trial: 3872304
Drug: Papaverine hydrochloride
RxNorm normalized name: Papaverine Hydrochloride
DrugBank: Papaverine (DB01113)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Papaverine hydrochloride (1 mg in 10 cc normal saline)
Trial: 3872304
Drug: Control (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (10 cc normal saline)
Trial: 16956818
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg zoledronic acid iv every 6 months (group A)
Trial: 16956818
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg zoledronic acid iv every 3 months (group B)
Trial: 10551639
Drug: Donor-specific transfusion
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donor-specific transfusion (DST) administered 24 hr before transplant and 7-10 days posttransplant
Trial: 25582800
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy for children (MBCT-C)
Trial: 24670086
Drug: Pancreatic enzyme
RxNorm normalized name: Pancreatic enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancreatic enzyme replacement therapy (PERT) (50,000 IU lipase)
Trial: 11882513
Drug: Low-dose glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose glucose infusion at a mean rate of 6 mg x kg(‐1) x min(‐1)
Trial: 11882513
Drug: High-dose glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose glucose infusion at a mean rate of 12 mg x kg(‐1) x min(‐1)
Trial: 9878012
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg famciclovir
Trial: 6795656
Drug: Maprotiline (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline (up to 150 mg/day for 2 weeks, then up to 300 mg/day if indicated)
Trial: 22803597
Drug: Atomoxetine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 20 mg twice daily
Trial: 22803597
Drug: Atomoxetine 60
RxNorm normalized name: atomoxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 60 mg twice daily
Trial: 21363899
Drug: Conventional ward
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional ward treatment
Trial: 17543656
Drug: RSI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSI plus etomidate bolus followed by continuous sedative infusion (ETO group)
Trial: 17543656
Drug: RSI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSI plus placebo followed by continuous sedative infusion (placebo group)
Trial: 12737240
Drug: Mandibular overdenture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular overdenture supported by two endosseous implants with a connecting bar
Trial: 10927737
Drug: Cocoa-bran cereal
RxNorm normalized name: bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa-bran cereal (25.0 g/d of total dietary fiber)
Trial: 10927737
Drug: Low-fiber cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fiber cereal (5.6 g/d of total dietary fiber)
Trial: 17822463
Drug: Trimethoprim (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (200 mg)
Trial: 8723472
Drug: Zidovudine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (200 mg), Trimethoprim (200 mg), Dapsone (100 mg)
Trial: 1328362
Drug: Low-dose angiotensin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose angiotensin II infusion
Trial: 2865712
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg dipipanone
Trial: 2865712
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg dipipanone
Trial: 2865712
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg dipipanone
Trial: 3312977
Drug: Dihydroergotamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine (0.5 mL, 1 mg/mL)
Trial: 31736068
Drug: AS04‐HPV‐16/18 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS04‐HPV‐16/18 vaccine (in Arms A and B)
Trial: 31736068
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (in Arms A/B and all Arm C)
Trial: 12667722
Drug: Apomorphine sublingual
RxNorm normalized name: apomorphine Sublingual Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apomorphine sublingual 4mg
Trial: 11082801
Drug: 8-week nurse-managed,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-week nurse-managed, peer-led smoking cessation intervention including 21 mg nicotine patch therapy for 6 weeks, weekly counseling, and skills training
Trial: 29680812
Drug: Smartphone application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smartphone application used weekly for 12 months
Trial: 29680812
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care involving regular (approximately 3 monthly) CF outpatient clinic appointments
Trial: 30634207
Drug: Jiedu Shengji
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jiedu Shengji Recipe (JSR), one dose per day for 8 weeks
Trial: 30634207
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: mixture of dexamethasone, lidocaine, and gentamicin, 10 mL each time before radiation
Trial: 23519913
Drug: Acidulated phosphate
RxNorm normalized name: Acidulated Phosphate Fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acidulated phosphate fluoride (APF) gel for 4 min
Trial: 23519913
Drug: Fractional CO(2)
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO(2) laser applied before APF gel (10 mJ, 200 Hz, 10 s)
Trial: 23519913
Drug: Fractional CO(2)
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO(2) laser applied through APF gel (10 mJ, 200 Hz, 10 s)
Trial: 22372591
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate 40 mg every second day
Trial: 22372591
Drug: Estradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol valerate 2 mg daily
Trial: 22372591
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of testosterone undecanoate and estradiol valerate
Trial: 20451681
Drug: Anakinra 100
RxNorm normalized name: ANAKINRA 100MG INJ,SYRINGE,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra 100 mg/day subcutaneously for 14 days
Trial: 12477078
Drug: Dimetindene (H1‐receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimetindene (H1‐receptor antagonist) plus cimetidine (H2‐receptor antagonist)
Trial: 15520068
Drug: Single-agent doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent doxorubicin
Trial: 7597425
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of doxorubicin and paclitaxel
Trial: 1575171
Drug: Quinapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (20 mg dose)
Trial: 6134626
Drug: Syrup of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup of ipecac
Trial: 27005470
Drug: Specific movement
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific movement control exercise (SMCE) combined with manual therapy
Trial: 27005470
Drug: General exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General exercise combined with manual therapy
Trial: 13680197
Drug: Displacement injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Displacement injection of 0.01 mg/kg of unlabelled flumazenil
Trial: 7723358
Drug: isradipine 2.5
RxNorm normalized name: isradipine 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isradipine 2.5 mg twice daily
Trial: 1687425
Drug: atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 100 mg daily
Trial: 7273647
Drug: Chemotherapy (randomised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (randomised between MOPP and LOPP) for patients with splenic involvement
Trial: 31935382
Drug: Transdermal contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal contraceptive patch with newly sourced adhesive component (test)
Trial: 31935382
Drug: EVRA patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVRA patch (reference)
Trial: 28600161
Drug: Healthy Living
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy Living Problem‐Solving (HELPS) intervention consisting of six group sessions conducted approximately monthly interspersed with individualized coaching calls.
Trial: 25112845
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sulodexide daily for 12 months
Trial: 25112845
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching dose) daily for 12 months
Trial: 21413691
Drug: Lecithin formulation
RxNorm normalized name: Lecithin
DrugBank: Lecithin (DB15834)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lecithin formulation (Meriva)
Trial: 19109001
Drug: Gentian violet
RxNorm normalized name: Gentian Violet
DrugBank: Gentian violet cation (DB00406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gentian violet aqueous solution 0.5%
Trial: 11506055
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g AG per day
Trial: 11506055
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g AG per day
Trial: 11506055
Drug: AG (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AG (15 g and 30 g)
Trial: 9760014
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate inhaled by Rotahaler (Becotide Rotacaps)
Trial: 9760014
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate inhaled by Cyclohaler (Beclomethasone Cyclocaps)
Trial: 9760014
Drug: Rescue medication
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue medication use in Rotahaler group
Trial: 8583466
Drug: Moexipril monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril monotherapy (7.5 or 15 mg once daily)
Trial: 8583466
Drug: Moexipril combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril combined with hydrochlorothiazide (7.5 or 15 mg daily with 25 mg hydrochlorothiazide)
Trial: 8583466
Drug: Moexipril monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril monotherapy or combination therapy
Trial: 2515971
Drug: Clonidine administration
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine administration
Trial: 29419533
Drug: Ergocalciferol 50,000
RxNorm normalized name: ergocalciferol 50,000 intl units oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ergocalciferol 50,000 IU once weekly for 8 weeks then once monthly for 4 months
Trial: 26147153
Drug: HBX (HYBENX®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBX (HYBENX® Oral Tissue Decontaminant™) in association with sub‐gingival ultrasonic debridement (UD)
Trial: 26147153
Drug: HBX (HYBENX®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBX (HYBENX® Oral Tissue Decontaminant™) as monotherapy
Trial: 26147153
Drug: Combined HBX-UD
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined HBX-UD treatment
Trial: 17328819
Drug: Garlic group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic group (400 mg garlic, 1 mg allicin, twice daily)
Trial: 17328819
Drug: Anethum group
RxNorm normalized name: Anethum graveolens leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anethum group (650 mg, twice daily)
Trial: 15167450
Drug: Irbesartan (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (an inhibitor of angiotensin II type 1 (AT1) receptors)
Trial: 12749519
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg QD
Trial: 7972803
Drug: Injection into
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection into the splenic artery (n=34)
Trial: 7972803
Drug: Injection into
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection into the superior mesenteric artery (SMA) (n=37)
Trial: 24491463
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium (MgSO4 50mg/kg in 100 mL of normal saline over 15 min before anesthesia induction, followed by an infusion of 15 mg/kg/hour)
Trial: 21689089
Drug: NT-proBNP level
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT-proBNP level ≥160ng/l
Trial: 16503677
Drug: High-CHO diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-CHO diet (6.5 g CHO kg body mass(‐1))
Trial: 16503677
Drug: Moderate-CHO diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-CHO diet (4.4 g CHO kg body mass(‐1))
Trial: 12757968
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment group
Trial: 30900008
Drug: Phendimetrazine 210
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phendimetrazine 210 mg
Trial: 30900008
Drug: Cocaine (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (0, 20, 40, and 80 mg intranasal)
Trial: 28751519
Drug: Intra-arterial treatment
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial treatment
Trial: 21262413
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) - three manualized sessions including one physical activity exposure session
Trial: 18655472
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (0.6 g protein/kg/day) balanced by high-calorie mix containing protein SUPRO 760 or ketosteril for 24-48 months
Trial: 17217711
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg and Irbesartan 150 mg
Trial: 8097114
Drug: Raclopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raclopride 2 mg
Trial: 8097114
Drug: Raclopride 6
RxNorm normalized name: PRUCALOPRIDE
DrugBank: Prucalopride (DB06480)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Raclopride 6 mg
Trial: 8097114
Drug: Raclopride 12
RxNorm normalized name: PRUCALOPRIDE
DrugBank: Prucalopride (DB06480)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Raclopride 12 mg